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CASE STUDY
Novel use of Absorbable Modified 
Polymer (AMP®); EndoClot™ as an adjunct  
in the management of bleeding from the liver 
bed during laparoscopic cholecystectomy
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Abstract 
Absorbable modified polymer (AMP) is a novel local haemostatic agent derived from a natural polysaccharide. 
Its safety and efficacy has been evaluated in upper and lower gastrointestinal bleeding without reported side 
effects. We report the safe use of AMP as an adjunct in the management of serious bleeding during laparoscopic 
cholecystectomy.
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Background
Serious intra-operative bleeding during laparoscopic 
cholecystectomy is rare with an incidence of less than 
2% (Tuveri and Tuveri 2007; Marakis et al. 2007; Vagenas 
et  al. 2006). The incidence is high in patients with liver 
disease, specifically, in cirrhosis with portal hypertension 
(Kaushik 2010). Absorbable Modified Polymer (AMP®) is 
a polysaccharide which is sprayed on to a bleeding sur-
face and acts by absorbing fluid and increasing the con-
centration of platelets, red blood cells and clotting factors 
at the site. Although short case series of using AMP in 
gastrointestinal bleeding are available (Halkerston et  al. 
2013; Patel et al. 2014) this is the first report of its intra-
peritoneal use.
Case presentation
A 36 year old male with child’s C cirrhosis presented with 
a history of repeated cholangitis resulting in encephalop-
athy. His clinical presentation was supported by further 
derangement of his liver enzyme status, serum biliru-
bin, and elevation in serum alkaline phosphatase levels. 
Trans-abdominal ultrasonic imaging revealed a dilated 
common bile duct with a calculus at its lower end and 
multiple calculi in the gallbladder. He was treated with 
intravenous antibiotics which resulted in improvement 
in his clinical status and part reversal of his biochemi-
cal parameters. A subsequent magnetic resonance chol-
angio-pancreatogram (MRCP) revealed that the calculi 
had spontaneously passed through the common bile 
duct, obviating the requirement for endoscopic extrac-
tion. Despite clinical improvement, his international 
normalized ratio (INR) continued to remain high at 2.5. 
To prevent further compromization of his liver func-
tion, a multi-disciplinary decision was made to undertake 
laparoscopic cholecystectomy. Following peri-operative 
transfusion of fresh frozen plasma (15  ml/kg) and par-
enteral vitamin K, his INR improved to 2; the platelet 
count was 1,300,000/mm3. Under general anesthesia, we 
undertook standard 4-port laparoscopic cholecystectomy 
as described previously (Liyanage et  al. 2006). In brief, 
pneumoperitoneum was achieved through an umbili-
cal port, to maintain an intraperitoneal carbon dioxide 
pressure of 12 mmHg. The liver appeared shrunken with 
an irregular surface. There were no significant varices 
around the Calot’s triangle. As the gallbladder was gen-
tly retracted cephalad with an atraumatic grasper the 
peritoneum over the posterior surface of liver became 
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detached which resulted in a minor bleed (Figure  1). 
The hemorrhage was arrested temporarily with local 
pressure. Simultaneously, the cystic duct and artery in 
Calot’s triangle were identified, clipped and divided, and 
the gallbladder was separated from the liver bed with 
use of an ultrasonic dissector. At the end of gallbladder 
removal, which took approximately 35 min, bleeding that 
had commenced at the inferior edge of the gall bladder 
attachment to the liver bed, was seen from the entire raw 
surface of the liver. High wattage electro-cautery of the 
bared liver surface combined with several applications of 
activated cellulose meshes failed to achieve satisfactory 
hemostasis. We used 2 g of absorbable modified polymer 
Endoclot™ (EndoClot Plus Inc, Santa Clara, CA, USA) 
which was sprayed over the surface of the bared liver 
to achieve hemostasis. The endoclot powder spray was 
delivered intra-peritoneally through a plastic catheter, 
provided by the manufacturer, introduced via a 5  mm 
reducer tube through the epigastric 10  mm port. This 
step is key, as passage of the catheter without the tube 
would have resulted in kinking of the catheter at the site 
of the port valve. The free end of the delivery catheter 
was connected to an air compressor pump device and the 
entire assembly activated at the pump switch as per man-
ufacturer’s instructions. The tip of the catheter was aimed 
at the site of bleeding using an atraumatic grasper (Fig-
ure  2). Thus, hemostasis was achieved rapidly and con-
firmed by laparoscopic observation for 10 min. The blood 
in the peritoneal cavity was sucked out and the port sites 
were closed after evacuation of pneumo-peritoneum. The 
patient was discharged from hospital after having made 
satisfactory recovery, without further blood loss.
Discussion
AMP is a polysaccharide derived from natural sources 
(Endoclotplus 2014). The substance has no reaction 
with components of human blood but promotes clot-
ting through a dehydrating mechanism increasing the 
concentration of clotting factors and cells at the site. 
The residual particles are lysed by amylase and glucoa-
mylase and is completely cleared from the site within 
few hours to days (Endoclotplus 2014). Halkerston et al. 
(2013) reported in a short case series of six patients 
treated with AMP as an adjunct in the management of 
upper gastrointestinal bleeding and colonic bleeding fol-
lowing endoscopic mucosal resection (EMR). Patel et al. 
2014 recently reported the safety and efficacy of AMP 
in 18 patients with a 89% (n  =  16) success in achiev-
ing hemostasis. In their case series the upper intestinal 
bleeds (n  =  16) were initially managed with adrena-
line injections, clipping and diathermy whereas for the 
lower intestinal bleeds (n = 3), all following EMR, argon 
plasma coagulation was also utilized. In two patients 
who developed delayed hemorrhage, despite initial 
response to AMP, the authors found a gastro intestinal 
stromal tumour (1) and a Dieulafoy lesion (2), suggest-
ing that use of Endoclot™ must be restricted to a facilita-
tory role and should not replace conventional attempts 
to achieve hemostasis. Our patient was a high-risk can-
didate for intraoperative bleeding due to existing liver 
failure. As bleeding occurred from the surface of the 
liver application of clips was not technically possible. 
Although AMP Endoclot™ has not been previously used 
at an intra-peritoneal site, there is evidence for safety of 
its use on raw surfaces as reported in EMR of colonic 
polyps (Halkerston et al. 2013; Patel et al. 2014). None of 
the case series in the literature has reported side effects 
with AMP usage.
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Figure 1 The site of liver bed bleeding (arrow) due to detachment of 
the peritoneal attachment of gall bladder.
Figure 2 AMP EndoClot™ being applied to the bleeding gall bladder 
bed via the plastic catheter guided by a grasper.
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